WinstonWongTanMDFACP
Oncology • Jacksonville, FLGenitourinary Oncology, Hematologic Oncology, Melanoma
Chair of Genitourinary Medical Oncology Program Director Hematology Oncology Fellowship
Dr. Tan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4500 San Pablo Road S
Jacksonville, FL 32224- Is this information wrong?
Summary
- Dr. Winston Tan is an oncologist in Jacksonville, FL and is affiliated with Mayo Clinic Hospital in Florida. He received his medical degree from University of Santo Tomas and has been in practice 31 years. He specializes in genitourinary oncology, hematologic oncology, and melanoma and is experienced in amyloidosis, hematologic oncology, testicular neoplasms, prostate cancer, and prostatitis.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 1997 - 2000
Maimonides Medical CenterResidency, Internal Medicine, 1991 - 1994
University of Santo TomasClass of 1986
Certifications & Licensure
FL State Medical License 2000 - 2026
TX State Medical License 1994 - 2026
MI State Medical License 1994 - 2013- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- FASCO American Society of Clinical Oncology, 2023
Clinical Trials
- Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer Start of enrollment: 2004 Apr 01
- Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer Start of enrollment: 2004 Aug 01
- Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer Start of enrollment: 2007 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with ad...Kathryn E Beckermann, Amita Patnaik, Ira Winer, Winston Tan, Babar Bashir, Christos E Kyriakopoulos, Randy F Sweis, Marc Chamberlain, Brian I Rini> ;Investigational New Drugs. 2024 Apr 1
- A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate canc...Mosalem, O., Tan, W., Bryce, A., Dronca, R., Childs, D., Pagliaro, L., Orme, J., Kase, A.> ;Prostate Cancer and Prostatic Diseases. 2024 Feb 10
- 3 citationsBayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer.Charles Blatti, Jesús de la Fuente, Huanyao Gao, Irene Marín-Goñi, Zikun Chen, Sihai D Zhao, Winston Tan, Richard Weinshilboum, Krishna R Kalari, Liewei Wang, Mikel He...> ;Cancer Research. 2023 Apr 14
- Join now to see all
Press Mentions
Cancer Survivors Find Support, Strength, HopeJune 3rd, 2018
Mayo Clinic to Host Public Cancer Education Symposium in OrlandoFebruary 22nd, 2017
Committees
- President, Florida Society of Clinical Oncology 2021 - 2023
Hospital Affiliations
Mayo Clinic Hospital in FloridaJacksonville, Florida- Mayo Clinic Hospital in FloridaJacksonville, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
